The alteration of IGF-1 levels and relationship between IGF-1 levels and growth velocity during GnRH analogue therapy
AuthorMuratoğlu Şahin, Nursel
Peltek Kendirci, Havva Nur
Savaş Erdeve, Şenay
MetadataShow full item record
CitationMuratoglu Sahin, N., Peltek Kendirci, H. N., Çetinkaya, S., Savas Erdeve, S., Aycan, Z. (2020). The alteration of IGF-1 levels and relationship between IGF-1 levels and growth velocity during GnRH analogue therapy. Journal of pediatric endocrinology & metabolism : JPEM, 33(1): 113-120.
Background: Some studies have examined the effect of gonadal suppression on insulin-like growth factor-1 (IGF-1) levels and the growth velocity (GV) with conflicting results.Methods: Forty-four girls treated with gonadotropin-releasing hormone analogue (GnRHa) for central precocious puberty (CPP) were included in the study. IGF-1 levels were examined at the beginning and after 12 months of treatment.Results: IGF-1 and IGF-1 standard deviation score (SUS) according to chronological age (CA-IGF-1 SUS) at diagnosis were positively correlated with chronological age (CA), anthropometric measurements, stage of puberty, bone age (BA), BA-CA, follicle-stimulating hormone (FSH), luteinising hormone (LH), oestradiol, uterus length, endometrium thickness and ovarian volume (OV) at diagnosis (p <0.05). There was no significant difference in IGF-1 levels after treatment. However, there was a negative correlation between Delta IGF-1 SDS and IGF-1 level, CA-IGF-1 SDS and BA-IGF-1 SDS at diagnosis (p <0.05). There was no correlation between GV and IGF-1, Delta IGF-1. GV was negatively correlated with basal LH level at diagnosis (p = 0.008, r=-0.397). Peak LH levels of the patients who had GV-SDS <0 were more suppressive than those of the patients who had GV-SDS> 0 after 12 months of treatment. Conclusions: It was determined that the IGF-1 level and CA-IGF-1 SDS at baseline were correlated with more advanced pubertal stage prior to treatment. Initiation of treatment with a relatively high level of IGF-1 increased the risk of a decrease in the IGF-1 level. Likewise, the initiation of treatment with a relatively high LH level may increase the risk of low GV, but low GV was not related to the IGF-1 level. Increased sex steroid suppression may increase the risk of low GV.